Molina David, Pérez-Beteta Julián, Martínez-González Alicia, Martino Juan, Velasquez Carlos, Arana Estanislao, Pérez-García Víctor M
Mathematical Oncology Laboratory (MÔLAB), Universidad de Castilla-La Mancha, Ciudad Real, Spain.
Neurosurgery Department, Hospital Universitario Marqués de Valdecilla and Fundación Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
PLoS One. 2017 Jun 6;12(6):e0178843. doi: 10.1371/journal.pone.0178843. eCollection 2017.
Textural measures have been widely explored as imaging biomarkers in cancer. However, their robustness under dynamic range and spatial resolution changes in brain 3D magnetic resonance images (MRI) has not been assessed. The aim of this work was to study potential variations of textural measures due to changes in MRI protocols.
Twenty patients harboring glioblastoma with pretreatment 3D T1-weighted MRIs were included in the study. Four different spatial resolution combinations and three dynamic ranges were studied for each patient. Sixteen three-dimensional textural heterogeneity measures were computed for each patient and configuration including co-occurrence matrices (CM) features and run-length matrices (RLM) features. The coefficient of variation was used to assess the robustness of the measures in two series of experiments corresponding to (i) changing the dynamic range and (ii) changing the matrix size.
No textural measures were robust under dynamic range changes. Entropy was the only textural feature robust under spatial resolution changes (coefficient of variation under 10% in all cases).
Textural measures of three-dimensional brain tumor images are not robust neither under dynamic range nor under matrix size changes. Standards should be harmonized to use textural features as imaging biomarkers in radiomic-based studies. The implications of this work go beyond the specific tumor type studied here and pose the need for standardization in textural feature calculation of oncological images.
纹理测量作为癌症成像生物标志物已得到广泛研究。然而,其在脑部三维磁共振成像(MRI)动态范围和空间分辨率变化下的稳健性尚未得到评估。本研究的目的是探讨由于MRI协议变化导致的纹理测量潜在变化。
本研究纳入了20例患有胶质母细胞瘤且有治疗前三维T1加权MRI的患者。对每位患者研究了四种不同的空间分辨率组合和三种动态范围。针对每位患者和每种配置计算了16种三维纹理异质性测量值,包括共生矩阵(CM)特征和游程矩阵(RLM)特征。变异系数用于评估在两个系列实验中测量值的稳健性,这两个实验分别对应于(i)改变动态范围和(ii)改变矩阵大小。
在动态范围变化下,没有纹理测量值是稳健的。熵是唯一在空间分辨率变化下稳健的纹理特征(在所有情况下变异系数均低于10%)。
三维脑肿瘤图像的纹理测量在动态范围和矩阵大小变化下均不稳健。在基于放射组学的研究中,应统一标准以将纹理特征用作成像生物标志物。本研究的意义不仅限于此处所研究的特定肿瘤类型,还提出了肿瘤图像纹理特征计算标准化的必要性。